Switch to:
More From Other Websites
Pfizer (PFE) Gains on Label Expansion Efforts for Ibrance Aug 28 2015
The 4 Stocks That Held Down the DJIA on Friday Aug 28 2015
What You Need To Know About 2 New S&P 500 Members Aug 28 2015
Credit Suisse's 8 Pharmaceutical Stocks With 'Significant' Upside Aug 28 2015
Dow 30 Stock Roundup: 3M Lowers 2015 Earnings Outlook, JNJ Subsidiary Sells Splenda Aug 28 2015
Research and Markets: China Latanoprost Market Investigation Report 2010-2019 Aug 28 2015
Big Lots goes big; Aeropostale misses; Smith & Wesson shoots higher Aug 28 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
Amgen wins approval for second biotech cholesterol drug Aug 27 2015
FDA proposes adding suffixes to distinguish biosimilar drug names Aug 27 2015
Cramer: China & biotech - it's complicated Aug 27 2015
Activision Blizzard, United Continental Holdings Set to Join the S&P 500 Aug 27 2015
Trade S&P 500 changes Aug 27 2015
Tracking today's volatility Aug 27 2015
At the close: Stocks snap back Aug 27 2015
FDA proposes adding suffixes to distinguish biosimilar drug names Aug 27 2015
FDA proposes adding suffixes to distinguish biosimilar drug names Aug 27 2015
Deutsche Bank Says Stick With Top Stocks Growing Dividends Aug 27 2015
More dividend cuts looming? Aug 26 2015
MannKind And Afrezza: Can The Drug Cure The Company? Aug 26 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 1 year ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK